Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 11.

Owen, Lucy, White, Alex W. ORCID: and Laird, Katie 2019. Characterisation and screening of antimicrobial essential oil components against clinically important antibiotic-resistant bacteria using thin layer chromatography-direct bioautography hyphenated with GC-MS, LC-MS and NMR. Phytochemical Analysis 30 (2) , pp. 121-131. 10.1002/pca.2797

Lau, Wing Man, Heard, Charles Martin ORCID: and White, Alex William ORCID: 2013. Design, synthesis and in vitro degradation of a novel co-drug for the treatment of psoriasis. Pharmaceutics 5 (2) , pp. 232-245. 10.3390/pharmaceutics5020232

White, Alex William ORCID:, Carpenter, Nicholas, Lottin, Jerome R. P., McClelland, Richard and Nicholson, Robert 2012. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine. European Journal of Medicinal Chemistry 56 , pp. 246-253. 10.1016/j.ejmech.2012.08.022

Lau, Wing Man ORCID:, Ng, Keng Wooi ORCID:, White, Alex William ORCID: and Heard, Charles Martin ORCID: 2011. Therapeutic and cytotoxic effects of the novel antipsoriasis codrug, naproxyl-dithranol, on HaCaT cells. Molecular Pharmaceutics 8 (6) , pp. 2398-2407. 10.1021/mp200327k

Lau, Wing Man ORCID:, White, Alex William ORCID:, Donaldson, M. and Heard, Charles Martin ORCID: 2010. Histochemical visualisation of esterase activity in porcine ear skin. Journal of Pharmacy and Pharmacology 62 (6) , p. 798. 10.1211/jpp.62.06.0016

Lau, Wing Man ORCID:, White, Alex William ORCID: and Heard, Charles Martin ORCID: 2010. Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining. Pharmaceutical Research 27 (12) , pp. 2734-2742. 10.1007/s11095-010-0274-8

Lau, Wing Man ORCID:, White, Alex William ORCID:, Gallagher, S. J., Donaldson, M., McNaughton, G. and Heard, Charles Martin ORCID: 2008. Scope and limitations of the co-drug approach to topical drug delivery. Current Pharmaceutical Design 14 (8) , pp. 794-802.

White, Alex William ORCID:, Westwell, Andrew ORCID: and Brahemi, Ghali 2008. Protein-protein interactions as targets for small-molecule therapeutics in cancer. Expert Reviews in Molecular Medicine 10 (e8) , pp. 1-14. 10.1017/S1462399408000641

White, Alex William ORCID:, Curtin, Nicola J., Eastman, Brian W., Golding, Bernard T., Hostomsky, Zdenek, Kyle, Suzanne, Li, Jianke, Maegley, Karen A., Skalitzky, Donald J., Webber, Stephen E., Yu, Xiao-Hong and Griffin, Roger J. 2004. Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. Biorganic and Medicinal Chemistry Letters 14 (10) , pp. 2433-2437. 10.1016/j.bmcl.2004.03.017

Perdomo-Lopez, I., Rodriguez-Perez, A. I., Yzquierdo-Peiro, J.M., White, Alex William ORCID:, Estrada, E. G., Villa, T. G. and Torres-Labandeira, J. J. 2002. Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: Experimental and computational studies. Journal of Pharmaceutical Sciences 91 (11) , pp. 2408-2415. 10.1002/jps.10237

White, Alex William ORCID:, Almassy, Robert, Calvert, A. Hilary, Curtin, Nicola J., Griffin, Roger J., Hostomsky, Zdenek, Maegley, Karen, Newell, David R., Srinivasan, Sheila and Golding, Bernard T. 2000. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. Journal of Medicinal Chemistry 43 (22) , pp. 4084-4097. 10.1021/jm000950v

This list was generated on Sat Apr 13 04:58:17 2024 BST.